Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

Omega-3 polyunsaturated fatty acids and docosahexaenoic acid appear to be associated with lower age-related macular ...

Soliddd Corp., a New York City-based optical and vision technology company, introduced its SolidddVision smart glasses ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based ...

Heart disease is often associated with the heart and arteries, but its effects extend far beyond the cardiovascular system.

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Number 5: The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with projections indicating strong uptake in biosimilars at the expense of the ...

Researchers have developed a highly efficient gene editing therapy that could potentially treat Stargardt disease, the most ...

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...